|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 295.50 DKK | +5.29% |
|
-20.04% | -9.15% |
| 08/02 | Hims to stop offering GLP-1 pill after FDA warned of crackdown | RE |
| 07/02 | How far are these giants from their peak? |
Chart calendar Novo Nordisk A/S
Upcoming events on Novo Nordisk A/S
| 26/03/2026 | Annual General Meeting | Add to your calendar Google Apple ICS format |
| 26/03/2026 | Investor Meeting | Add to your calendar Google Apple ICS format |
| 06/05/2026 | Q1 2026 Earnings Release | Add to your calendar Google Apple ICS format |
| 05/08/2026 | Q2 2026 Earnings Release | Add to your calendar Google Apple ICS format |
| 04/11/2026 | Q3 2026 Earnings Release | Add to your calendar Google Apple ICS format |
| 03/02/2027 | Q4 2026 Earnings Release (Projected) | Add to your calendar Google Apple ICS format |
| 06/05/2027 | Q1 2027 Earnings Release (Projected) | Add to your calendar Google Apple ICS format |
| 11/08/2027 | Q2 2027 Earnings Release (Projected) | Add to your calendar Google Apple ICS format |
| 03/11/2027 | Q3 2027 Earnings Release (Projected) | Add to your calendar Google Apple ICS format |
Past events on Novo Nordisk A/S
| 05/02/2026 | Q4 2025 Earnings Call - London |
| 04/02/2026 | Q4 2025 Earnings Call |
| 03/02/2026 | Q4 2025 Earnings Release |
| 13/01/2026 | JP Morgan Healthcare Conference |
| 14/11/2025 | Extraordinary Shareholders Meeting |
| 11/11/2025 | American Association for the Study of Liver Diseases Meeting - Oral Presentation No:0174 |
| 10/11/2025 | American Association for the Study of Liver Diseases Meeting - Poster No:4042 |
| 10/11/2025 | American Association for the Study of Liver Diseases Meeting - Oral Presentation No:0010 |
| 10/11/2025 | American Association for the Study of Liver Diseases Meeting - Oral Presentation No:0148 |
| 09/11/2025 | American Association for the Study of Liver Diseases Meeting - Poster No:3086 |
| 08/11/2025 | American Association for the Study of Liver Diseases Meeting - Poster No:2625 |
| 08/11/2025 | American Association for the Study of Liver Diseases Meeting - Poster No:2545 |
| 08/11/2025 | American Association for the Study of Liver Diseases Meeting - Poster No:2075 |
| 08/11/2025 | American Association for the Study of Liver Diseases Meeting - Poster No:2570 |
| 08/11/2025 | American Association for the Study of Liver Diseases Meeting - Poster No:2052 |
| 07/11/2025 | ObesityWeek - Semaglutide 7.2 mg |
| 07/11/2025 | ObesityWeek - ASCVD Risk |
| 06/11/2025 | Q3 2025 Earnings Call - London |
| 06/11/2025 | ObesityWeek - World Risk of CV |
| 06/11/2025 | ObesityWeek - Semaglutide 2.4 mg |
Past dividends on Novo Nordisk A/S
| 15/08/2025 | Interim Payment 3.75 DKK |
| 28/03/2025 | Final Payment 7.9 DKK |
| 15/08/2024 | Interim Payment 3.5 DKK |
| 22/03/2024 | Final Payment 6.4 DKK |
| 18/08/2023 | Interim Payment 6 DKK |
| 24/03/2023 | Final Payment 8.15 DKK |
| 12/08/2022 | Interim Payment 4.25 DKK |
| 25/03/2022 | Final Payment 6.9 DKK |
| 16/08/2021 | Interim Payment 3.5 DKK |
| 26/03/2021 | Final Payment 5.85 DKK |
| 14/08/2020 | Interim Payment 3.25 DKK |
| 27/03/2020 | Final Payment 5.35 DKK |
| 16/08/2019 | Interim Payment 3 DKK |
| 22/03/2019 | Final Payment 5.15 DKK |
| 17/08/2018 | Interim Payment 3 DKK |
| 23/03/2018 | Final Payment 4.85 DKK |
| 18/08/2017 | Interim Payment 3 DKK |
| 24/03/2017 | Final Payment 4.6 DKK |
| 12/08/2016 | Interim Payment 3 DKK |
| 21/03/2016 | Annual 6.4 DKK |
Annual results
| Fiscal Period | December | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|
|
Net sales Million DKK | Released Forecast Spread | 232 261 228 920 1.46% | 290 403 285 429 1.74% | 309 064 307 426 0.53% | 292 375 | 309 065 | 326 786 |
|
EBITDA Million DKK | Released Forecast Spread | 111 987 109 530 2.24% | 147 446 141 939 3.88% | 149 640 149 253 0.26% | 137 714 | 146 372 | 155 740 |
|
EBIT Million DKK | Released Forecast Spread | 102 574 101 255 1.3% | 128 339 126 210 1.69% | 127 658 128 737 -0.84% | 118 753 | 125 976 | 133 110 |
|
Earnings before Tax (EBT) Million DKK | Released Forecast Spread | 104 674 102 184 2.44% | 127 191 125 432 1.4% | 130 540 130 622 -0.06% | 120 540 | 125 053 | 132 245 |
|
Net income Million DKK | Released Forecast Spread | 83 683 82 021 2.03% | 100 988 100 215 0.77% | 102 434 102 607 -0.17% | 93 968 | 98 073 | 104 954 |
|
EPS DKK | Released Forecast Spread | 18,6 18,3 1.79% | 22,6 22,3 1.67% | 23,0 23,0 0.13% | 21,2 | 22,3 | 24,6 |
| Announcement Date | 31/01/24 | 05/02/25 | 03/02/26 | - |
Quarterly results
| Fiscal Period | December | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 Q3 | 2026 Q4 | 2027 Q1 | 2027 Q2 | 2027 Q3 | 2027 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million DKK | Released Forecast Spread | 68 060 68 563 -0.73% | 71 311 71 869 -0.78% | 85 683 80 179 6.86% | 78 087 78 019 0.09% | 76 857 77 114 -0.33% | 74 976 77 075 -2.72% | 79 144 76 674 3.22% | 75 190 | 71 193 | 70 849 | 70 950 | 74 645 | 75 895 | 74 355 | 81 225 |
|
EBITDA Million DKK | Released Forecast Spread | 34 779 29 430 18.17% | 35 972 36 184 -0.59% | 41 935 36 501 14.89% | 42 621 40 715 4.68% | 38 282 38 965 -1.75% | 31 439 34 245 -8.19% | 37 298 39 048 -4.48% | 33 444 | 34 085 | 34 200 | 27 700 | ||||
|
EBIT Million DKK | Released Forecast Spread | 25 934 27 258 -4.86% | 33 822 33 301 1.57% | 36 737 32 939 11.53% | 38 791 36 740 5.58% | 33 449 34 694 -3.59% | 23 682 24 684 -4.06% | 31 736 31 267 1.5% | 36 920 | 28 851 | 28 493 | 24 752 | ||||
|
Earnings before Tax (EBT) Million DKK | Released Forecast Spread | 25 332 27 740 -8.68% | 34 384 33 325 3.18% | 35 557 31 943 11.31% | 37 033 35 000 5.81% | 33 805 34 568 -2.21% | 25 517 26 943 -5.29% | 34 185 33 366 2.45% | 30 835 | 29 625 | 28 390 | 23 086 | ||||
|
Net income Million DKK | Released Forecast Spread | 20 050 22 116 -9.34% | 27 301 26 877 1.58% | 28 230 25 743 9.66% | 29 034 27 298 6.36% | 26 503 27 136 -2.33% | 20 006 21 390 -6.47% | 26 891 25 969 3.55% | 23 233 | 22 556 | 22 097 | 19 270 | 23 626 | 22 000 | 21 000 | 21 702 |
|
EPS DKK | Released Forecast Spread | 4,49 4,71 -4.72% | 6,12 5,98 2.32% | 6,34 5,76 10.06% | 6,53 6,15 6.1% | 5,96 6,07 -1.87% | 4,50 4,59 -1.91% | 6,04 5,89 2.63% | 5,24 | 5,10 | 5,00 | 4,37 | 5,31 | 4,94 | 4,72 | 4,88 |
| Announcement Date | 07/08/24 | 06/11/24 | 05/02/25 | 07/05/25 | 06/08/25 | 05/11/25 | 03/02/26 | - | - | - | - | - | - | - | - |
| 09/02/2026 | Q3 2026 Earnings Release | Add to your calendar Google Apple ICS format | |
| 09/02/2026 | Q3 2026 Earnings Release | Add to your calendar Google Apple ICS format | |
| 09/02/2026 | Q3 2025 Earnings Release | Add to your calendar Google Apple ICS format | |
| 09/02/2026 | Q3 2025 Earnings Release | Add to your calendar Google Apple ICS format | |
| 09/02/2026 | Q3 2026 Earnings Release | Add to your calendar Google Apple ICS format | |
| 09/02/2026 | Q3 2026 Earnings Release | Add to your calendar Google Apple ICS format | |
| 09/02/2026 | Q3 2026 Earnings Release | Add to your calendar Google Apple ICS format | |
| 09/02/2026 | Q3 2026 Earnings Release | Add to your calendar Google Apple ICS format | |
| 09/02/2026 | Q3 2026 Earnings Release | Add to your calendar Google Apple ICS format | |
| 09/02/2026 | Q4 2025 Earnings Release | Add to your calendar Google Apple ICS format |
Past sector events for Novo Nordisk A/S
| 07/02/2026 | Q3 2026 Earnings Release | |
| 06/02/2026 | Q3 2026 Earnings Release | |
| 06/02/2026 | Q3 2025 Earnings Release | |
| 06/02/2026 | Q3 2026 Earnings Release | |
| 06/02/2026 | Q3 2026 Earnings Release | |
| 06/02/2026 | Q4 2025 Earnings Release (Projected) | |
| 06/02/2026 | Q3 2025 Earnings Release | |
| 06/02/2026 | Q3 2025 Earnings Release | |
| 06/02/2026 | Q3 2025 Earnings Release | |
| 05/02/2026 | Q3 2026 Earnings Release |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- NOVO B Stock
- Calendar Novo Nordisk A/S
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















